Your Health, We Care
Release date: 2024-07-10 15:07:56 Recommended: 217
Selpercatinib LOXO-292 is a RET kinase inhibitor used to treat three types of cancer: adult metastatic RET fusion positive non-small cell lung cancer (NSCLC) patients; Adult and pediatric advanced or metastatic RET mutation positive medullary thyroid cancer (MTC) patients aged 12 and above who require systematic treatment; Adult and pediatric advanced or metastatic RET fusion positive thyroid cancer patients aged 12 and above who are refractory to radioactive iodine and require systematic treatment.
At a grand pharmaceutical exhibition held recently in Dubai, Lucius Company of L···【more】
Recommended：353Release date: 2024-07-09
On October 18-19, 2023, Dr. Luís Meirinhos Soares, a microbiology expert appoint···【more】
Recommended：362Release date: 2024-07-09
On October 19, 2023, the World Health Organization (WHO) conducted a comprehensi···【more】
Recommended：422Release date: 2024-07-09
At present, the competition in all walks of life is very fierce, especially in t···【more】
Recommended：283Release date: 2024-07-09
Here are some key points about Lucius Pharmaceutical:Lucius Pharmaceuticals has ···【more】
Recommended：476Release date: 2024-07-09
From the Black Sea, the most terrifying ocean on earth, to the Mediterranean Sea···【more】
Recommended：294Release date: 2024-07-09
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently mad···【more】
Recommended：461Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest incr···【more】
Recommended：365Release date: 2024-07-09
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the r···【more】
Recommended：67Release date: 2025-12-17
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved nirap···【more】
Recommended：60Release date: 2025-12-15
The U.S. Food and Drug Administration (FDA) announced today that it has approved···【more】
Recommended：79Release date: 2025-12-10
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisoca···【more】
Recommended：74Release date: 2025-12-08
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full ap···【more】
Recommended：94Release date: 2025-12-04
Primary analysis data from the randomized, double-blind, placebo-controlled phas···【more】
Recommended：89Release date: 2025-12-01
